Article
Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design.
Protein and peptide letters - 1 Jan 2008
Wang Jing-Fang, Wei Dong-Qing, Chen Chao, Li Yixue, Chou Kuo-Chen
Abstract excerpt
CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
